AI assistant
Sending…
HAEMONETICS CORP — Director's Dealing 2020
Apr 8, 2020
31565_dirs_2020-04-08_fad54e6f-fa12-4913-b6cc-352cc4e47767.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2020-04-01
Reporting Person: Lingamneni Anila (EVP, Chief Technology Officer)
More from HAEMONETICS CORP
Annual Report
2026
Jun 9
Proxy Solicitation & Information Statement
2026
Jun 9
Proxy Solicitation & Information Statement
2026
Jun 9
Regulatory Filings
2026
Jun 5
Regulatory Filings
2026
May 28
Annual Report
2026
May 20
Major Shareholding Notification
2026
May 13
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 1
Major Shareholding Notification
2026
Apr 30